Trial intelligence / Profile preview

Topical tranexamic acid in hallux valgus surgery

ChiCTR2300078897Phase 4Recruiting

Sponsor
Beijing Jishuitan Hospital
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in bunion deformity (HAV) (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Forefoot circumference change. Started Dec 2023; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

bunion deformity (HAV)

Beyond the preview

Go deeper on ChiCTR2300078897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call